AcuCort AB (ACUC.ST)

SEK 0.65

(-3.25%)

Net Income Summary of AcuCort AB

  • AcuCort AB's latest annual net income in 2023 was -13.69 Million SEK , up 7.42% from previous year.
  • AcuCort AB's latest quarterly net income in 2024 Q2 was -3.8 Million SEK , down -5.26% from previous quarter.
  • AcuCort AB reported an annual net income of -14.78 Million SEK in 2022, down -30.63% from previous year.
  • AcuCort AB reported an annual net income of -11.32 Million SEK in 2021, down -45.79% from previous year.
  • AcuCort AB reported a quarterly net income of -3.8 Million SEK for 2024 Q2, down -5.26% from previous quarter.
  • AcuCort AB reported a quarterly net income of -4.31 Million SEK for 2023 Q4, down -37.69% from previous quarter.

Annual Net Income Chart of AcuCort AB (2023 - 2016)

Historical Annual Net Income of AcuCort AB (2023 - 2016)

Year Net Income Net Income Growth
2023 -13.69 Million SEK 7.42%
2022 -14.78 Million SEK -30.63%
2021 -11.32 Million SEK -45.79%
2020 -7.76 Million SEK 7.21%
2019 -8.36 Million SEK -34.56%
2018 -6.21 Million SEK -33.44%
2017 -4.66 Million SEK -139.54%
2016 -1.94 Million SEK 0.0%

Peer Net Income Comparison of AcuCort AB

Name Net Income Net Income Difference
AlzeCure Pharma AB (publ) -37.16 Million SEK 63.164%
BioGaia AB (publ) 365.35 Million SEK 103.747%
Enzymatica AB (publ) -49.72 Million SEK 72.468%
Enorama Pharma AB (publ) -44.61 Million SEK 69.312%
Gabather AB (publ) -9.43 Million SEK -45.078%
Klaria Pharma Holding AB (publ.) -35.78 Million SEK 61.74%
Moberg Pharma AB (publ) -21.09 Million SEK 35.092%
Nanexa AB (publ) -76.39 Million SEK 82.079%
Newbury Pharmaceuticals AB (publ) -15.4 Million SEK 11.126%
ODI Pharma AB 355.97 Thousand SEK 3946.1%
Orexo AB (publ) -128.3 Million SEK 89.329%
Probi AB (publ) 16.81 Million SEK 181.402%
Swedencare AB (publ) 58.6 Million SEK 123.363%
Swedish Orphan Biovitrum AB (publ) 2.4 Billion SEK 100.568%
Toleranzia AB -7.45 Million SEK -83.55%
Vivesto AB -367.03 Million SEK 96.27%